Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Exelon (Rivastigmine Tartrate) Capsules
Company:  Novartis Pharmaceuticals Corporation
Application No.:  20-823
Approval Date: 4/21/2000


Date created: October 11, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.